# Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day

> **NCT00596115** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Bennett, James P., Jr., M.D., Ph.D.**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** R(+) pramipexole dihydrochloride monohydrate

## Key facts

- **NCT ID:** NCT00596115
- **Lead sponsor:** Bennett, James P., Jr., M.D., Ph.D.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-07-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596115, "Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00596115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*